@topologic_apple @mike_lustgarten Original study: https://t.co/mdWSXzxvKw
RT @DrPalmquist: A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetyl…
RT @DrPalmquist: A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetyl…
RT @DrPalmquist: A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetyl…
RT @DrPalmquist: A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetyl…
A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo - PubMed https://t.co/X9J8grT3Ll
Hard to swallow: neutraceuticals do not help symptoms of bipolar depression https://t.co/LY5sXzBaDY
RT @ASBDD_EMCR: A randomised controlled trial of a mitochondrial therapeutic target for #bipolardepression: mitochondrial agents, #N-acetyl…
A randomised controlled trial of a mitochondrial therapeutic target for #bipolardepression: mitochondrial agents, #N-acetylcysteine, and placebo https://t.co/YpjQu2o0Ub
RT @IMPACTSRC: This study examined two add-on treatments in bipolar depression and provided a number of novel findings despite having an ov…
RT @IMPACTSRC: This study examined two add-on treatments in bipolar depression and provided a number of novel findings despite having an ov…
This study examined two add-on treatments in bipolar depression and provided a number of novel findings despite having an overall negative outcome as a trial. See: https://t.co/12supofexR #BipolarDisorder #Depression #HaveAnIMPACT https://t.co/SCsUAVpFAW
New from #The_MRC https://t.co/qyqyUGcSb7 A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo
A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo. - PubMed - NCBI https://t.co/84k3sf2qJu
A randomised controlled #trial of a mitochondrial therapeutic target for bipolar #depression: mitochondrial agents, N-acetylcysteine, and placebo @Deakin https://t.co/pL7hpg0wTn